Relative Ratio and Level of Amyloid-β 42 Surrogate in Cerebrospinal Fluid of Familial Alzheimer Disease Patients with Presenilin 1 Mutations

Publisher： Karger

E-ISSN： 1660-2862|13|2-3|166-170

ISSN： 1660-2854

Source： Neurodegenerative Diseases, Vol.13, Iss.2-3, 2013-10, pp. : 166-170

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Increased Cerebrospinal Fluid Aβ38/Aβ42 Ratio in Alzheimer Disease

By  

Neurodegenerative Diseases, Vol. 2, Iss. 5, 2006-02 ,pp. : 242-245

Karger

Access to resources Recommend Favorite

Cerebrospinal Fluid Profile of Amyloid β Peptides in Patients with Alzheimer’s Disease Determined by Protein Biochip Technology

By  

Neurodegenerative Diseases, Vol. 1, Iss. 4-5, 2004-11 ,pp. : 231-235

Karger

Access to resources Recommend Favorite

Cerebrospinal Fluid Biomarkers in Alzheimer’s Disease Families with PSEN1 Mutations

By  

Neurodegenerative Diseases, Vol. 8, Iss. 4, 2011-01 ,pp. : 202-207

Karger

Access to resources Recommend Favorite

Analysis of APL1β28, a Surrogate Marker for Alzheimer Aβ42, Indicates Altered Precision of γ-Cleavage in the Brains of Alzheimer Disease Patients

By  

Neurodegenerative Diseases, Vol. 7, Iss. 1-3, 2010-02 ,pp. : 42-45

Karger

Access to resources Recommend Favorite

Prediction of Alzheimer’s Disease Using a Cerebrospinal Fluid Pattern of C-Terminally Truncated β-Amyloid Peptides

By  

Neurodegenerative Diseases, Vol. 5, Iss. 5, 2008-02 ,pp. : 268-276

Karger

Access to resources Recommend Favorite